A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...
Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.
The Indian government currently has no plans to ban Ranitidine, a stomach acid reducer, despite international concerns about impurities. Actions include testing and communication with drug ...
This is a threat that should not be underestimated. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Phishing is a form of cyberattack in ...